Diagnostic Accuracy of NICE Classification to Predict Deep Submucosal Invasion (NICE)

Diagnostic Accuracy of NICE Classification to Predict Deep Submucosal Invasion in Colon Lesions. Prospective Multicenter Study in Routine Clinical Practice

The purpose of this study is to evaluate the diagnostic accuracy of NICE classification to predict deep submucosal invasion of colonic polyps > 1 cm, considering histology as the gold standard, in a group of endoscopists who previously performed a training program.

Study Overview

Status

Completed

Conditions

Detailed Description

In the first phase of the study, a learning program of NICE classification based on examples will be performed. Forty images will be evaluated before and after the learning program.

In the second phase of the study, all consecutive patients who underwent to a colonoscopy will be included if a lesion greater than 1 cm is found and the endoscopy is performed with a high definition colonoscope with Narrow Band Imaging (NBI). Patients, lesions and endoscopy equipment characteristics will be recorded.

Subsequently, histological diagnosis of the lesion will also be recorded. Evaluated test (NICE classification) was blinded to the pathologist who performed the gold standard test (histology). In case of adenocarcinomas, histological predictors of lymph node metastases, with predefined assessment criteria, will also be recorded.

Finally, histological preparations of adenocarcinomas will be sent to the reference center and two experienced pathologists will examine them again.

Study Type

Interventional

Enrollment (Actual)

2171

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Barcelona
      • Manresa, Barcelona, Spain, 08241
        • Ignasi Puig

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion patients criteria:

  • Patients> 18 years
  • Lesion Type 0 of Paris classification, greater than 1 cm, found in a colonoscopy performed by any medical indication with a high definition endoscope with Narrow Band Imaging.
  • Achievable histology by endoscopic or surgical resection.
  • Writing informed consent given.

Exclusion patients criteria:

  • Age <18 years.
  • Refusal to give informed consent.
  • Contraindication for endoscopic or surgical resection.
  • Urgent colonoscopy indication (eg severe rectorrhagia.).
  • Patients with inflammatory bowel disease.
  • Suspected metastatic neoplasia by previous imaging tests.

Exclusion lesions criteria:

  • Polyp previously biopsied or resected.
  • Poor preparation that does not allow a proper assessment of the lesion.
  • NBI not performed.
  • Unavailable or indefinite histology (endoscopic or surgical resection).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: NBI used by trained endoscopists
Assessment with NICE classification and NBI technology of colonic lesions (Paris classification type 0) greater than 1 cm found in a routine colonoscopy. This assessment was performed by previously trained endoscopists.
Examination of colon lesions, using NBI and NICE classification, by endoscopists who previously performed an easy learning program. The learning program consists on the reading of two reference articles and a tutorial explaining the NICE classification. This tutorial shows several lesions and describes the characteristic features in which the classifications focus on.
Other Names:
  • Narrow Band Imaging
  • NICE classification

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic accuracy of NICE classification to predict deep submucosal invasion
Time Frame: 1 year

Sensibility, specificity, negative predictive value and positive predictive value of NICE classification to predict deep submucosal invasion during routine colonoscopies.

Gold standard (histology):

  • positive means adenocarcinoma with deep submucosal invasion (>1 mm)
  • negative means non adenocarcinoma or superficial adenocarcinoma (<1 mm)

Evaluated test (NICE classification):

  • Positive means NICE type 3.
  • Negative means NICE type 1 and 2.

Evaluated test (NICE classification) was blinded to the pathologist who performed the gold standard test (histology)

1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic accuracy of NICE classification to predict deep submucosal invasion in the pre-learning test
Sensibility, specificity, negative predictive value and positive predictive value of NICE classification to predict deep submucosal invasion in the pre-learning test.
Diagnostic accuracy of NICE classification to predict deep submucosal invasion in the post-learning test
Sensibility, specificity, negative predictive value and positive predictive value of NICE classification to predict deep submucosal invasion in the post-learning test (pre-clinical test)
Preplanned potential factors that could influence diagnostic accuracy of NICE classification
Time Frame: 1 year

Related to the lesion: Size (mm); location: rectum/sigmoid/left colon/splenic flexure/transverse colon/hepatic flexure/right colon and cecum; Morphology according to the Paris classification (see categories in the reference article); Level of confidence: high/low; Successful complete submucosal injection: yes/no/not done; Chicken skin's sign: yes/no; Edges retraction: yes/no; Depressed areas: yes/no; Folds convergence: yes/no; Induration: yes/no; Obvious ulceration: yes/no; Polyp on polyp: yes/no; Technical resection: 8 categories according to the current practice.

Related to the equipment: Colonoscope: 11 colonoscope models; Videoprocessor: Exera II, Exera III; Monitor: high definition, non-high definition

Related to the endoscopist: Hospital type: Secondary or tertiary; Endoscopy experience (number of years); Previous experience in chromoendoscopy: yes/no; Previous experience in NBI: yes/no; Number of lesions included in the study; Review histology and images monthly: yes/no

1 year
Histological predictors of lymph node metastases of pT1
Time Frame: 1 year
  • Histological type: adenocarcinoma, mucinous adenocarcinoma, cell carcinoma with signet ring, undifferentiated carcinoma, other.
  • Histologic Grade: Low Grade (well-moderately differentiated) or High-grade (poorly dif, undifferentiated, mucinous, signet ring).
  • Horizontal size of adenocarcinoma (mm)
  • Level of submucosal adenocarcinoma (mm)
  • Angiolymphatic invasion of small vessels: Present or absent
  • Perineural invasion: Present or Absent.
  • Tumor budding: Absent, Low grade (5-9 groups of 5 cells per field with 20x objective), High Grade (≥10 groups of 5 cells per field with 20x objective)
  • Polyp type that originated carcinoma: Tubular adenoma, Villous adenoma, Adenoma/sessile serrated polyp, Traditional serrated adenoma, Other
  • Resection margin: Negative or Positive
  • Size of negative margin (mm).
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pablo Vega, Complexo Hospitalario De Ourense
  • Principal Investigator: Maria Luisa de Castro, Complexo Hospitalario Universitario de Vigo-CHUVI
  • Principal Investigator: Eva Martínez-Bauer, Corporacion Parc Tauli
  • Principal Investigator: Angel Fernández, Hospital Clínico de Zaragoza
  • Principal Investigator: Gema de la Poza, Hospital De Fuenlabrada
  • Principal Investigator: Jorge López, Hospital De Mostoles
  • Principal Investigator: Oscar Nogales, Gregorio Marañon hospital
  • Principal Investigator: Beatriz Peñas, Hospital Universitario Ramon y Cajal
  • Principal Investigator: Pilar Díez, Hospital Río Ortega
  • Principal Investigator: Marta Hernández, Hospital Universitario Puerta de Hierro
  • Principal Investigator: Antonio Zebenzuy, Hospital Universitario de Canarias
  • Principal Investigator: Aurora Burgos, Hospital Universitario La Paz
  • Principal Investigator: Jorge Mendoza, Hospital La Princesa
  • Principal Investigator: Marco Antonio Álvarez, Hospital del Mar

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2014

Primary Completion (Actual)

July 1, 2016

Study Completion (Actual)

July 1, 2016

Study Registration Dates

First Submitted

December 8, 2014

First Submitted That Met QC Criteria

December 26, 2014

First Posted (Estimate)

December 31, 2014

Study Record Updates

Last Update Posted (Actual)

June 27, 2018

Last Update Submitted That Met QC Criteria

June 26, 2018

Last Verified

June 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colonic Polyps

Clinical Trials on NBI used by trained endoscopists

Subscribe